Sign inSign up

ADSA Society

Logo
IssuesFor AuthorsAdvertisingNewsHelp

ADSA Society

Search Results

You are looking at 1-10 of 196

Three Newly Approved Analgesics: An Update
Mana Saraghi DMD and
 Elliot V. Hersh DMD, MS, PhD
Article Category: Other
Volume/Issue: Volume 60: Issue 4
Online Publication Date: Jan 01, 2013
DOI: 10.2344/0003-3006-60.4.178
Page Range: 178 – 187

, improved healing, reduced health care costs, and improved patient satisfaction, but it may play a role in preventing the progression of chronic pain. 4 – 6 Opioids have traditionally been the most common analgesic for treating moderate to severe postoperative pain. 2 However, their utility is hampered by undesirable side effects, which are sometimes intolerable to the patient. These side effects include central nervous depression, respiratory depression, pruritus, nausea, vomiting, ileus, tolerance, and opioid-induced hyperalgesia. 4 – 6 By treating pain with

Download PDF
Daniel E. Becker
Figure 2
Figure 2

Analgesic efficacy. This graph illustrates a typical dose-response curve for orally administered (PO) analgesics. The dose-response curve for opioids such as morphine demonstrates unlimited efficacy in which greater doses provide greater analgesia. At equipotent doses, all opioids demonstrate a similar dose response. In contrast, nonopioids demonstrate a “ceiling” effect that generally is adequate for relief of mild to moderate pain (pain relief rating of 4–5 in this scale). For ibuprofen, doses greater than 400 mg do not provide further analgesia. For aspirin (ASA) and acetaminophen (APAP), this ceiling effect is achieved at 1000 mg and is somewhat lower than that provided by nonsteroidal anti-inflammatory drugs (NSAIDs).


Daniel E. Becker
Figure 3
Figure 3

Molecular structures of morphine, codeine, and derivatives. The top row illustrates molecular structures for morphine and its two derivatives, hydromorphone and oxymorphone. The subtle changes indicated by the asterisks enhance affinity for the opioid receptors, which accounts for greater potency. The bottom row illustrates codeine and its derivatives, which differ from their morphine-derived counterparts only in a methyl substitution (circled). Approximately 60% of an oral dose of codeine-related products is absorbed and may be subjected to varying degrees of demethylation by CYP2D6 to its active metabolite. Framed molecules are those credited with the analgesic effect provided by various codeine-related products. Codeine has little affinity for opioid receptors. Roughly 10% of an absorbed dose is demethylated to morphine, which is credited with its analgesic effect. Hydrocodone and oxycodone have good receptor affinity and provide an analgesic effect. The analgesic effect of hydrocodone is credited to both the parent drug and its active metabolite, hydromorphone, but analgesia provided by oxycodone is almost entirely the result of the parent drug. Very little is demethylated to oxymorphone.


Daniel E. Becker DDS
Article Category: Research Article
Volume/Issue: Volume 57: Issue 2
Online Publication Date: Jan 01, 2010
Page Range: 67 – 79

Pain is a complex experience consisting of a specific sensation and the reactions evoked by that sensation. Conventional analgesics either interrupt ascending nociceptive impulses or depress their interpretation within the central nervous system (CNS). A variety of so-called “analgesic adjuncts” have proven efficacy for managing chronic pain but will not be addressed in this article. They include various antidepressants and anticonvulsants that either enhance descending inhibitory pathways or modulate excitatory neural traffic that amplifies

Daniel E. Becker DDS and
 James C. Phero DMD
Article Category: Other
Volume/Issue: Volume 52: Issue 4
Online Publication Date: Jan 01, 2005
Page Range: 140 – 149

Analgesic drugs interrupt nociceptive pathways that transmit impulses to be interpreted as pain in the central nervous system. Conventional analgesics inhibit ascending impulses and/or their interpretation. Figure 1 offers a basic schematic of nociceptive transmission. A variety of so-called ‘‘analgesic adjuncts’’ have proven efficacy for managing chronic pain, but will not be addressed in this article. They include various antidepressants and anticonvulsants that either enhance descending inhibitory pathways or modulate excitatory neural traffic, which

Shigeru Maeda DDS, PhD,
 Hitoshi Higuchi DDS, PhD,
 Maki Fujimoto DDS,
 Saki Miyake DDS,
 Yuka Honda-Wakasugi DDS, PhD, and
 Takuya Miyawaki DDS, PhD
Article Category: Research Article
Volume/Issue: Volume 67: Issue 3
Online Publication Date: Sep 29, 2020
Page Range: 140 – 145

, face, and neck. Thus, the level of surgical invasiveness of a ramus osteotomy is typically considered to be intermediate, somewhere between minor and major surgeries. Ideal evidence-based protocols designed to provide postoperative analgesia specifically for ramus osteotomy procedures have not yet been established. Presently there are various analgesics available for administration in the perioperative period, such as NSAIDs, acetaminophen, and opioid agonists. Although combined use of these analgesics is typically expected to be appropriate for managing

Atsushi Hanzawa DDS, PhD,
 Toshiyuki Handa DDS, PhD,
 Yoshihiko Kohkita DDS, PhD,
 Tatsuya Ichinohe DDS, PhD, and
 Ken-Ichi Fukuda DDS, PhD
Article Category: Research Article
Volume/Issue: Volume 65: Issue 1
Online Publication Date: Jan 01, 2018
Page Range: 24 – 29

Minor oral surgical procedures, such as dissection and detachment of the gingival mucosa and periosteum or removal of bone tissue, are relatively invasive, with a high incidence of postoperative pain, the level of which is frequently high. 1 – 3 Postoperative pain may be caused by postsurgical inflammation secondary to invasive stimulation, and it markedly affects patient recovery and satisfaction. 4 – 6 Therefore, postoperative pain relief is important and drugs having not only a strong analgesic effect but also anti-inflammatory effects

Ken-ichi Fukuda,
 Masakazu Hayashida,
 Kazutaka Ikeda,
 Yoshihiko Koukita,
 Tatsuya Ichinohe, and
 Yuzuru Kaneko
Figure 5
Figure 5

Relationships between analgesic efficacy of fentanyl (%MPE) and A118G genotypes.


Ken-ichi Fukuda,
 Masakazu Hayashida,
 Kazutaka Ikeda,
 Yoshihiko Koukita,
 Tatsuya Ichinohe, and
 Yuzuru Kaneko
Figure 2
Figure 2

Frequency of need for postoperative analgesics following sagittal split mandibular osteotomy (SSMO) compared with that following oral soft tissue surgery.


Peggy Compton,
 Steven Wang,
 Camron Fakhar,
 Stacey Secreto,
 Olivia Halabicky Arnold,
 Brian Ford, and
 Elliot V. Hersh
Figure 3.
Figure 3.

Analgesic Doses Taken During the First 72 Hours Postoperatively in Opioid-Using and Opioid-Naïve Patients.

Patients with chronic pain on opioid therapy used more analgesics (mean, SD) during the first 72 hours postoperatively vs opioid-naïve patients without chronic pain.


ANPR logo
AboutIssuesAuthor InformationSubscriptions

ADSA Society

eISSN: 1878-7177

ISSN: 0003-3006

Powered by PubFactory